Business Wire - June 14, 2002
These test results demonstrated that the VScan(TM) TB Test Kit has a sensitivity of 80% and specificity of 100%. The only test kit currently available has a sensitivity of 60%. Sensitivity is defined as the repetition of a positive result in individuals with the disease in question. Specificity is defined as the repetition of a negative result in individuals without the disease.
The VScan(TM) Test Kit is a cost-effective, easy-to-use test which does not require any medical or skilled personnel. The TB kit produces visible results, which are easy to interpret in under 20 minutes. In addition, the kit requires no electricity or refrigeration and can be safely stored at room temperature. This allows the kit to be used in a variety of environments and settings. A built-in control mechanism ensures the integrity of the kit.
Tuberculosis (TB) is a highly contagious disease caused by bacteria (Mycobacterium tuberculosis) which strikes people in their most productive years, ages 15 to 44. The World Health Organization declared TB a global health crisis in 1993.
It is transmitted through air contaminated with droplets released from the lungs. Of the 2 billion people infected with TB, 200 million worldwide will develop active TB and be able to infect others. Eight (8) million new cases of TB are diagnosed each year. Three (3) million people die from TB every year. TB is the leading killer of woman ages 15 to 44, surpassing all causes of maternal mortality. TB kills more adults than ALL other infectious diseases combined. TB is the leading killer of people infected with HIV worldwide (source: World Health Organization).
About Medical Services International Inc.
Medical Services International Inc. is a medically related holding company comprised of two core businesses. The company operates medical facilities on Anguilla, B.W.I., that supply medical diagnostic services and dialysis. The facility combines the recreational aspects of a Caribbean destination with the availability of North American quality medical services. The diagnostic test division was created in response to a worldwide demand for less costly, rapid technically simplified test methods to test for infectious diseases. The company has developed its VScan(TM) Rapid Test Kits for the detection of HIV 1 & 2, Hepatitis B and C and Tuberculosis. The company is currently in negotiations with major healthcare concerns to supply these tests to the worldwide market.
Medical Services International Inc. has also acquired a strategic interest in a call center operator (Teltek International Limited) based in the British West Indies. The call center operation operates full-service call centers with the latest customer relationship management technology specializing in providing call center out-sourcing solutions and out-bound telemarketing services to major U.S. multi-national corporations.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF."
For further information, please contact Robert Talbot at 780/430-6363, or Bill Whitehead, Jr. at 416/822-5883; Corporate Website: www. MedicalServicesIntl.com
Note: Certain statements in this news release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include, but are not limited to, new economic conditions, risk in product technology developments, market acceptance of new product and continuing product demand, level of competition and other factors described in the company reports, prospectus and other filings with the Securities and Exchange Commission.
CONTACT: Medical Services International Inc. Robert Talbot, 780/430-6363 Bill Whitehead, Jr., 416/822-5883
SOURCE: Medical Services International Inc.
020614
BW020609
Copyright © 2002 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .